MedPath

Lidocaine Hydrochloride

LIDOCAINE HYDROCHLORIDE INJECTION, USP

Approved
Approval ID

f98b8ed2-5faa-d998-e053-6394a90ac71d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 17, 2023

Manufacturers
FDA

Medical Purchasing Solutions, LLC

DUNS: 601458529

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

LIDOCAINE HYDROCHLORIDE

PRODUCT DETAILS

NDC Product Code71872-7301
Application NumberANDA083158
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateApril 17, 2023
Generic NameLIDOCAINE HYDROCHLORIDE

INGREDIENTS (4)

HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
LIDOCAINE HYDROCHLORIDEActive
Quantity: 20 mg in 1 mL
Code: V13007Z41A
Classification: ACTIR

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.